Literature DB >> 26599750

Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Shingo Kato1, Murilo Foppa2, Sébastien Roujol2, Tamer Basha2, Sophie Berg2, Kraig V Kissinger2, Beth Goddu2, Warren J Manning3, Reza Nezafat4.   

Abstract

BACKGROUND: Native T1 mapping has emerged as a noninvasive non-contrast magnetic resonance imaging (MRI) method to assess for diffuse myocardial fibrosis. However, LV native T1 time in AF patients and its clinical relevance are unclear.
METHODS: Fifty paroxysmal AF patients referred for PVI (60 ± 8 years, 37 male) and 11 healthy control subjects (57 ± 8 years, 10 male) were studied. All patients were in sinus rhythm during the MRI scan. Native T1 mapping images were acquired using a Modified Look-Locker imaging (MOLLI) sequence in 3 short-axis planes (basal, mid and apical slices) using an electrocardiogram triggered single-shot acquisition with a balanced steady-state free precession readout. Late gadolinium enhanced (LGE) MRI was acquired to evaluate for LV myocardial scar.
RESULTS: LV ejection fraction was similar between groups (AF: 61 ± 6%; controls: 60 ± 6%, p=0.75). No LV myocardial scar was observed in any patient on LGE. Myocardial native T1 time was greater in AF patients (1099 ± 52 vs 1042 ± 20 msec, p<0.001). During a median follow-up period of 326 days, 18 of 50 (36%) patients experienced recurrence of AF. Multivariate Cox proportional hazard analysis identified elevated native T1 time as an independent predictor of recurrence of AF (HR: 6.53, 95% CI: 1.25-34.3, p=0.026).
CONCLUSIONS: There are differences in the native LV myocardial T1 time between AF patients with preserved LV function referred for PVI and normal controls. Native T1 time is an independent predictor of recurrence of AF after PVI in patients with paroxysmal AF.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cardiomyopathy; Fibrosis; Magnetic resonance imaging; Recurrence of atrial fibrillation; T(1) mapping

Mesh:

Year:  2015        PMID: 26599750      PMCID: PMC4734756          DOI: 10.1016/j.ijcard.2015.11.073

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  45 in total

1.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

Authors:  Simon Stewart; Carole L Hart; David J Hole; John J V McMurray
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

2.  Association of atrial fibrillation and aortic atherosclerosis: a population-based study.

Authors:  Y Agmon; B K Khandheria; I Meissner; G L Schwartz; T M Petterson; W M O'Fallon; F Gentile; P C Spittell; J P Whisnant; D O Wiebers; J L Covalt; J B Seward
Journal:  Mayo Clin Proc       Date:  2001-03       Impact factor: 7.616

3.  Diffuse ventricular fibrosis measured by T₁ mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation.

Authors:  Alex J A McLellan; Liang-han Ling; Sonia Azzopardi; Andris H Ellims; Leah M Iles; Michael A Sellenger; Joseph B Morton; Jonathan M Kalman; Andrew J Taylor; Peter M Kistler
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08-20

4.  Accelerated late gadolinium enhancement cardiac MR imaging with isotropic spatial resolution using compressed sensing: initial experience.

Authors:  Mehmet Akçakaya; Hussein Rayatzadeh; Tamer A Basha; Susie N Hong; Raymond H Chan; Kraig V Kissinger; Thomas H Hauser; Mark E Josephson; Warren J Manning; Reza Nezafat
Journal:  Radiology       Date:  2012-07-19       Impact factor: 11.105

5.  Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.

Authors:  Liang-Han Ling; Peter M Kistler; Andris H Ellims; Leah M Iles; Geraldine Lee; Gerard L Hughes; Jonathan M Kalman; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2012-11-07       Impact factor: 24.094

6.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: an analysis of over 600-patients.

Authors:  Tae-Hoon Kim; Junbeom Park; Jin-Kyu Park; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Int J Cardiol       Date:  2014-08-08       Impact factor: 4.164

8.  Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE.

Authors:  Sébastien Roujol; Sebastian Weingärtner; Murilo Foppa; Kelvin Chow; Keigo Kawaji; Long H Ngo; Peter Kellman; Warren J Manning; Richard B Thompson; Reza Nezafat
Journal:  Radiology       Date:  2014-04-04       Impact factor: 11.105

9.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Authors:  Valentina O Puntmann; Tobias Voigt; Zhong Chen; Manuel Mayr; Rashed Karim; Kawal Rhode; Ana Pastor; Gerald Carr-White; Reza Razavi; Tobias Schaeffter; Eike Nagel
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

10.  Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.

Authors:  Daniel M Sado; Steven K White; Stefan K Piechnik; Sanjay M Banypersad; Thomas Treibel; Gabriella Captur; Marianna Fontana; Viviana Maestrini; Andrew S Flett; Matthew D Robson; Robin H Lachmann; Elaine Murphy; Atul Mehta; Derralynn Hughes; Stefan Neubauer; Perry M Elliott; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-05       Impact factor: 7.792

View more
  5 in total

1.  Pooled summary of native T1 value and extracellular volume with MOLLI variant sequences in normal subjects and patients with cardiovascular disease.

Authors:  Ha Q Vo; Thomas H Marwick; Kazuaki Negishi
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-04       Impact factor: 2.357

2.  Variability of native T1 values: implication for defining regional myocardial changes using MRI.

Authors:  Kai Lin; Kenichiro Suwa; Heng Ma; Jeremy D Collins; Michael Markl; James C Carr
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-22       Impact factor: 2.357

Review 3.  Prognostic value of non-contrast myocardial T1 mapping in cardiovascular diseases: a systematic review and meta-analysis.

Authors:  Meng-Xi Yang; Hong-Bing Luo; Jie-Ke Liu; Xue-Ming Li; Chun-Hua Wang; Ke Shi; Jing Ren; Peng Zhou
Journal:  Heart Fail Rev       Date:  2022-01-22       Impact factor: 4.654

4.  Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.

Authors:  Lei Zhao; Songnan Li; Chen Zhang; Jie Tian; Aijia Lu; Rong Bai; Jing An; Andreas Greiser; Jie Huang; Xiaohai Ma
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-22       Impact factor: 5.364

5.  Prognostic Significance of Left Ventricular Fibrosis Assessed by T1 Mapping in Patients with Atrial Fibrillation and Heart Failure.

Authors:  Lei Zhao; Songnan Li; Xiaohai Ma; Rong Bai; Nian Liu; Ning Li; Paul Schoenhagen; Changsheng Ma
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.